8-K - Avalo Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

of this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amen

Financial Results

8.01

Other Events. The Company has posted on its website an updated investor presentation (the “Investor Presentation”). The Investor Presentation will be used from

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Investor Presentation. 104 The cover pages of this Current Report on Form 8-K, for

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1